pillbase.ru

Medroxyprogesterone Acetate

Active substance: medroxyprogesterone

TABLET · MEDROXYPROGESTERONE ACETATE 5 mg/1

United StatesActive

Marketing holder: A-S Medication Solutions

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 11
  • Депо-Провера®
    суспензия для внутримышечного введения, 150 мг/мл, 150 мг (original in Russian, GRLS)
    ЛП-№(006375)-(РГ-RU)
    Пфайзер Инк
  • Депо-Провера®
    суспензия для внутримышечного введения, 150 мг/мл, 1 мл (original in Russian, GRLS)
    П N008862/01
    Пфайзер Инк.
  • Медроксипрогестерона ацетат
    субстанция-порошок, ~, 0.1 -5 кг (original in Russian, GRLS)
    П N013033/01
    Кристал Фарма С.А.
  • Провера
    таблетки, 500 мг (original in Russian, GRLS)
    ЛП-№(005340)-(ГП-RU)
    Пфайзер Инк
  • Провера®
    таблетки, 500 мг (original in Russian, GRLS)
    П N011853/01
    Пфайзер Инк
All products in this country (11)
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-67f6-7215-a602-1c62ed87af9c,01a1208c-825b-7bd8-be23-8d6ea4c9b252,01a1208c-933b-7251-9d80-400a366dd8a3,01a1208c-bb11-7eb6-bff6-933f94b4d623,01a1208c-d053-74b6-b1ff-600cf395a2b4;count=48 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
50090-0491
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 50090-0491 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 50090-0491 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 50090-0491 · Verified 2026-10-09 · open in source